Clinical trials consume a significant portion of the pharmaceutical industry’s research budget at approximately $78billion/year. Yet 80% of these clinical trials are delayed or closed due to issues with recruitment, with 37% of sites under-enrolling volunteers and 11% failing to enroll even one patient.1 The problem is staggering in terms of absolute financial and human costs. … [Read more...]